Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score

Table 2

Comparison of observed and FRS-predicted CVD risk in patients with psoriasis.

Group	Number of patients	CVD events		SIR (95% CI)
		Observed	FRS-predicted
Total	1197	82	71.7	1.14 (0.92, 1.42)
Female	632	33	25.7	1.28 (0.92, 1.79)
Male	565	49	45.9	1.07 (0.81, 1.41)
Age
<60 years	879	34	33.5	1.01 (0.73, 1.41)
60+ years	318	48	38.1	1.26 (0.95, 1.68)
No systemic treatment	1364	71	61.8	1.15 (0.91, 1.45)
Any systemic treatment	198	11	9.8	1.12 (0.62, 2.03)

FRS: Framingham risk score; CVD: cardiovascular disease; SIR: standardized incident ratio; CI: confidence interval.